Literature DB >> 26464726

The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?

Qin A Chang1, Abdulraheem Qasem2, Sheshadri Madhusudhana2, Alexey Glazyrin1.   

Abstract

Double-hit lymphomas (DHL) are defined as B-cell lymphoma with a chromosomal breakpoint affecting the MYC/8q24 locus in combination with rearrangement at (14;18)(q32;q21). We recently observed three cases of B-cell lymphoma with an extra intact MYC signal in association with the t(14;18)(q32;q21) translocation. The impact of an extra copy of MYC to the clinical course and prognosis of one patient with Diffuse Large B Cell Lymphoma (DLBCL) and two patients with Follicular Lymphoma (FL) was evaluated. Flow cytometry in all cases demonstrated lambda- or kappa-light chain restricted CD20 and CD10 positive neoplastic B cells. FISH analysis was negative for MYC gene rearrangement but demonstrated an extra copy of intact MYC. Tissue sections displayed typical starry sky "gray zone" lymphoma morphology in case of DLBCL and FL morphology in cases 2 and 3, with high Ki67 labeling in all three cases. All patients responded well to initial chemotherapy although displayed variant outcome after initial remission. The patient with DLBCL deceased within a year of diagnosis while the other two patients with FL showed much better overall survival. Our limited experience showed that additional copy of intact MYC may be equivalent to "classic" DHL on the background of DLBCL with additional cytogenetic abnormalities, however isolated t(14;18)(q32;q21) translocation in combination with additional copy of intact MYC may demonstrate histology and clinical outcome more comparable with "classic" low grade follicular lymphoma, albeit with more aggressive morphology.

Entities:  

Keywords:  Double hit lymphoma; MYC; amplification; follicular lymphoma; translocation

Mesh:

Year:  2015        PMID: 26464726      PMCID: PMC4583958     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Authors:  Shaoying Li; Pei Lin; Luis E Fayad; Patrick A Lennon; Roberto N Miranda; C Cameron Yin; E Lin; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2011-10-14       Impact factor: 7.842

Review 2.  MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.

Authors:  Adam M Petrich; Chadi Nabhan; Sonali M Smith
Journal:  Cancer       Date:  2014-07-24       Impact factor: 6.860

3.  Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Authors:  Monica Testoni; Ivo Kwee; Timothy C Greiner; Santiago Montes-Moreno; Julie Vose; Wing C Chan; Annalisa Chiappella; Luca Baldini; Andrés J M Ferreri; Gianluca Gaidano; Michael Mian; Emanuele Zucca; Francesco Bertoni
Journal:  Br J Haematol       Date:  2011-04-13       Impact factor: 6.998

Review 4.  The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.

Authors:  Itziar Salaverria; Reiner Siebert
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

5.  Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.

Authors:  Nicola J Foot; Robert G Dunn; Helen Geoghegan; Bridget S Wilkins; Michael J Neat
Journal:  J Clin Pathol       Date:  2011-05-18       Impact factor: 3.411

Review 6.  Myc pathways provoking cell suicide and cancer.

Authors:  Jonas A Nilsson; John L Cleveland
Journal:  Oncogene       Date:  2003-12-08       Impact factor: 9.867

7.  Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.

Authors:  Carlo Valentino; Samantha Kendrick; Nathalie Johnson; Randy Gascoyne; Wing C Chan; Dennis Weisenburger; Rita Braziel; James R Cook; Raymond Tubbs; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Elaine Jaffe; Wenjun Zhang; Patrick Brunhoeber; Hiro Nitta; Tom Grogan; Lisa Rimsza
Journal:  Am J Clin Pathol       Date:  2013-02       Impact factor: 2.493

8.  Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

Authors:  Yasuhiro Oki; Mansoor Noorani; Pei Lin; Richard E Davis; Sattva S Neelapu; Long Ma; Mohamed Ahmed; Maria Alma Rodriguez; Fredrick B Hagemeister; Nathan Fowler; Michael Wang; Michelle A Fanale; Loretta Nastoupil; Felipe Samaniego; Hun J Lee; Bouthaina S Dabaja; Chelsea C Pinnix; Leonard J Medeiros; Yago Nieto; Issa Khouri; Larry W Kwak; Francesco Turturro; Jorge E Romaguera; Luis E Fayad; Jason R Westin
Journal:  Br J Haematol       Date:  2014-06-18       Impact factor: 6.998

9.  The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.

Authors:  Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; S Jane Kendall; Roger G Owen; Andrew P Haynes; Gareth J Morgan; Andrew S Jack
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

10.  Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.

Authors:  A N Seo; J M Yang; H Kim; S Jheon; K Kim; C T Lee; Y Jin; S Yun; J-H Chung; J H Paik
Journal:  Br J Cancer       Date:  2014-05-08       Impact factor: 7.640

View more
  2 in total

1.  Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.

Authors:  Antonin Bouroumeau; Eleonore Kaphan; Clémentine Legrand; Tatiana Raskovalova; Gautier Szymanski; Claire Vettier; Christine Lefebvre; Marie-Christine Jacob; Anne McLeer; Michel Peuchmaur; Rémy Gressin; Hervé Sartelet
Journal:  J Med Case Rep       Date:  2020-07-27

2.  'Blastoid' variant of Burkitt lymphoma with additional partial 1q tetrasomy.

Authors:  Ahsan Siddiqi; Sheshadri Madhusudhana; Alexey Glazyrin
Journal:  Mol Clin Oncol       Date:  2018-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.